From Crisis Aversion to Cost Reduction - Managed Care Insights on Enhancing Ketone Monitoring for Diabetic Ketoacidosis Prevention

Program Description

Diabetic ketoacidosis (DKA) is a life-threatening complication of diabetes, often occurring in people with type 1 diabetes, though there is a rising prevalence among individuals with type 2 diabetes in certain situations, such as with the use of SGLT2 inhibitors or during pregnancy. Delayed treatment of DKA can result in increased readmission, complications, and a significant economic burden on the healthcare system. Managing DKA effectively requires careful monitoring of ketones, but current methods for monitoring DKA are inconsistent and often inaccurate. Managed care professionals should be aware of DKA monitoring developments and integrate continuous ketone monitoring with glucose monitoring to improve patient outcomes, decrease the risk of complications, and reduce health care resource utilization. Recent advancements in continuous ketone monitoring being integrated with a continuous glucose monitoring system have the potential to transform DKA management by reducing delayed diagnoses and enhancing patient safety. This supplement will present the most recent data available on emerging ketone monitoring technology, and contextualize the importance of reducing the incidence of DKA in populations at high risk for managed care professionals.

Target audience: Managed care pharmacists

Type of activity: Application

Release date: April 1, 2026

Expiration date: April 1, 2027

Learner level: Foundational, Intermediate, Advanced

Time to complete activity: 3.0 hours

Fee: Free

Educational Objectives

At the completion of this activity, participants will be able to:

• Identify risk factors and populations at high risk for diabetic ketoacidosis (DKA)
• Illustrate the societal, economic, and clinical burden of DKA on patients and the health care system.
• Examine approaches for ketone monitoring, interpretation, and utility in the prevention and management of DKA.
• Analyze the potential cost-effectiveness of continuous ketone monitoring (CKM) compared with traditional DKA monitoring methods and the role of CKM to improve patient outcomes.

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 3.0 contact hours (0.30 CEUs) under the ACPE universal activity number 0290-0000-25-042-H05-P. The activity is available for CE credit through April 1, 2027.

Instructions for Completing the Activity and Receiving CPE Credit

To receive CPE credit, participants must complete the pretest, view the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.

Faculty

Joshua J. Neumiller, PharmD, CDCES, FADCES, FASCP,  has the following relevant financial relationship with a commercial interest to disclose:

Consultant: Proteomics International

Kristina Naseman, PharmD, MPH, BCACP, BC-ADM, CDCES; and Carrie McAdam-Marx, PhD, RPh, have no relevant financial relationships with commercial interests to disclose.

EDITORIAL SUPPORT DISCLOSURES

Kelsey Giara, PharmD, RPh; Jeannette Y. Wick, RPh, MBA, FASCP; and Brianna Winters, MA, have no relevant financial relationships with commercial interests to disclose.

Pharmacy Times Continuing Education™ Planning Staff: Jim Palatine, RPh, MBA; Dipti Desai, PharmD, MBA, CHCP; Kylie Ferrentino; Susan Pordon; and Chloe Taccetta have no relevant financial relationships with commercial interests to disclose.

Any relevant financial relationships listed for these individuals have been mitigated.

At least one anonymous peer reviewer was used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with ineligible companies to disclose.

Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:
ceinfo@pharmacytimes.com
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms